New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2004 to 2023. Read More.
Open Access Percentage
75%
Total
Publications
110
Total Open
Publications
82
Total
Citations
3.2K
Open Access
Percentage
75%
Total
Publications
110
Total Open
Publications
82
Total
Citations
3.2K
Breakdown
Publisher Open
8%
Both
50%
Other Platform Open
16%
Closed
26%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 47%
30
Hybrid 36%
23
No Guarantees 17%
11
Other Platform Open
Domain 62%
45
Preprint 30%
22
Other Internet 23%
17
Institution 11%
8
Public 8%
6
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 43 |
Europe PMC | Domain | 23 |
Research Square | Preprint | 12 |
bioRxiv | Preprint | 12 |
Unknown Repository | Other Internet | 9 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 6 |
Semantic Scholar | Public | 4 |
DOI | Other Internet | 3 |
University of Nottingham - Repository@Nottingham | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |